Venter Pharma

Spain
Alcobendas, Madrid, Spain

Company profile

Venter Pharma company profile

Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals. It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively. Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose

Business identity

Contact email
[email protected]
Phone number
(+34) 91 625 21 89
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2003-01-01, Year

Headquarters

Country code
ES
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$4.8M
Last funding
Series Unknown / $4.8M / 2014-03-05
Last equity funding
Series Unknown / $4.8M
Investors
3
Lead investors
1

Founders and investors

Lead investors

Grupo Ferrer Internacional

Investors

Clave CapitalEISMEAGrupo Ferrer Internacional